Republic Republic Republic
  • Log in
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
Primary market Live deals Secondary market Buy and sell Republic Note Own a piece of Republic's upside Investor Network Membership Receive exclusive discounts and benefits
Republic Venture Opportunities for accredited investors
Republic Capital Multi-stage venture firm Republic Digital Crypto hedge fund
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain Asset management Explore digital asset funds
Republic Capital In-house Venture Capital fund Broker dealer Regulated capital services
Log in Sign up

Republic Republic Republic
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
  • US
  • Log in
  • Sign up
All investors
Primary market Live deals Secondary market Buy and sell Republic Note Own a piece of Republic's upside Investor Network Membership Receive exclusive discounts and benefits
Accredited only
Republic Venture Opportunities for accredited investors
Institutional
Republic Capital Multi-stage venture firm Republic Digital Crypto hedge fund
More
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Spotlight deal
Hamilton Lane Private Infrastructure Fund
Hamilton Lane Private Infrastructure Fund
Get unique access to the full spectrum of private markets with Hamilton Lane
Growth capital solutions
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets
Sharedrops Gift equity as a reward
Web3 services
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain Asset management Explore digital asset funds
Institutional services
Republic Capital In-house Venture Capital fund
Broker dealer Regulated capital services

Predictiv isn't accepting new investments

Predictiv’s deadline was June 12, 2021

Follow the company to stay updated on their progress, including future investment opportunities


Explore new investment opportunities:
View companies raising now
Campaign ended
Logo of Predictiv

Predictiv

The DNA-based Digital Twin to predict and prevent risks on 16,000+ diseases
Genomics Fight Disease
Facebook Telegram Twitter LinkedIn
Featured image of Predictiv
$807,600
Raised
1,575
Investors
Successfully funded and closed on June 12, 2021.
Invest in Predictiv

Open for investment

Investors in Predictiv also invested in these companies. View more
Logo of Eli Roth's The Horror Section

Eli Roth's The...

A brand-new independent studio from an iconic horror...

Republic Funding Portal · Reg CF
Logo of The Catholic Herald

The Catholic Herald

The world’s oldest Catholic publication is undergoin...

Republic Funding Portal · Reg CF
Logo of RYSE

RYSE

Smart Shades for your Smart Home - over $9mm in sale...

Capital R · Reg A+
Logo of Revolution Race Cars

Revolution Race Cars

Building the Best Race Car on Earth to bring Top Tie...

Republic Funding Portal · Reg CF
Logo of Freedom Chat

Freedom Chat

A private social messaging app transforming the soci...

Republic Funding Portal · Reg CF
Loading...
Pitch Updates 9 Reviews 283
Invest Invest in Predictiv
Facebook Telegram Twitter LinkedIn
Closed on June 12, 2021. Information may not be up-to-date. Campaign closed on June 12, 2021. Information displayed may not be up-to-date.
Problem Solution Product Traction Customers Biz. model Market Competition Vision and strategy Funding Founders
About Team Press

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by Predictiv Care. View the official SEC filing and all updates:
Official SEC Logo Form C SEC.gov
Company documents
Predictiv Crowd SAFE Predictiv Form CA.pdf Predictiv Form C.pdf
Loading

Hear from some of the 1,575 investors in Predictiv


Show more

Highlights


Bootstrapped
High traction without any outside capital
  • A comprehensive solution to assess the level of risk on 16,000 diseases
  • The ability to simulate personalized reaction to 300+ drugs
  • A unique advanced genomics pipeline (>95% automated)
  • An A.I. engine validated at the FDA COVID-19 challenge
  • Two patents filed
  • Projected revenue of $70M by 2024
  • 18 months to break even, and will have a 75% operating margin

Problem


55 million people die every year from a life-threatening disease

55M people die every year from a serious disease. But did you know that over 10% of serious diseases have a genetic component and could have been prevented! 

Amongst them:

  • 15% of all cancers have an inherited susceptibility
  • 12% of all hospital admissions are a result of genetic causes
  • 10% of all chronic diseases (diabetes, heart disease, Alzheimer's) have significant genetic components. 

The problem is, we don’t have an efficient way to monitor genetic markers – we need a ‘minority report’ for health. 

Solution


Predictiv is a DNA-based digital twin that assesses risks for 16K+ diseases

Predictiv is the future of medicine. Using DNA Next Generation Sequencing, we assess the level of risk on 16K+ diseases. In addition to that, we also sequence 20K+ genes and analyze 300+ drugs. Our DNA-based digital twin evolves, simulates reactions to 300+ drugs, presents real-time data and is completely searchable.

Product


From your fingernail to your personalized preventive plan

  1. Everything starts with your DNA sample. After you receive your kit, just follow the instructions and send back your DNA sample (finger- or toenails). 
  2. Once received, we extract your DNA, sequence it, and analyze it to create your Digital Twin.
  3. We then send you an invitation to take an online or face-to-face consultation with a genetic counselor who will take the time to get into details with you and set-up your personalized preventive plan.

Traction


Our genomics pipeline is 95%+ automated

Predictiv has spent 4 years developing the future of medicine. We now have an AI engine that was validated during the COVID-19 challenge organized in June/July 2020 with a genomics pipeline that is 95% automated. We also have filed two patents and have competed at the FDA challenge for COVID-19 data where we ranked 14th amongst the 35 major organizations participating, including Google, Accenture, and UCSF. We were 8th to predict the length of ICU hospitalization due to COVID-19.

We are currently discussing with more than 30 prominent organizations (healthcare providers, telemedicine companies...) who have shown great interest.

We are in final discussions for contracts covering 40,000 healthcare professionals and over 300 clinics in the USA, India and South East Asia. We expect those contracts to be signed soon and the first deployments to be started in March.

Customers


Helping patients and healthcare workers alike

Predictiv allows patients to assume full control over their genetic profile, empowering them to make accurate and recommended health decisions. Likewise, it allows healthcare workers access to early diagnoses and optimal drug doses and recommendations. 

Business model


$790/person

Predictiv costs $790 per unit, which includes Next Generation Sequencing and your consultation with a genetic counselor trained on our solution. We have created a mass-market solution that helps healthcare professionals, hospitals and governments address the genetic components of long-term and serious diseases. 

Our solution can either be prescribed or recommended by a healthcare professional, or ordered directly on our website.

Market


67% of US adults are interested in getting genetic testing to determine risks

67% of US adults are interested in getting genetic testing to determine risks. With the growing market for genetic testing and the billions of dollars spent on disease research, Predictiv projects $70M in revenue by 2024. We will only need 18 months to break even, and will have a 75% operating margin. 

Competition


The most complete solution on the market

When current alternatives on the market have to research manually every time they want to cover a disease, our approach has been to screen them all and compare it to the 20,000 genes of your body. To our knowledge, we are the only solution to cover 99% of diseases known to have genetic components.

Thanks to our fully automated process, Predictiv provides information on 1,000 times more diseases than major solutions on the market!

Vision and strategy


Genetic testing and sequencing is just the start

Predictiv plans to provide health and analytical data on virtually all aspects of health. While we are starting with genomic sequencing and genetic testing, we plan to launch a fully scaled health and medical data platform, which will also bring the world of nutrition and fitness into the future. 

Funding


Predictiv is asking $1M to launch the solution

Predictiv is asking for $1M to improve our UI/UX, execute partnerships in the USA and Asia, and expand our solution.

Founders


A team of experts & entrepreneurs

Founded by recognized genomics experts, Sajung and Sijung Yun,  and a serial entrepreneur with 2 successful exits, Alex Rochegude, Predictiv has been built on the academic expertise and the entrepreneurship experience that is required to change the way medicine is done today.

Deal terms


Valuation cap

$5,500,000

The maximum valuation at which your investment converts into equity shares or cash.
Learn more

Discount

0%

If a trigger event for Predictiv occurs, the discount provision gives investors equity shares (or equal value in cash) at a reduced price.
Learn more.

Minimum investment

$100

The smallest investment amount that Predictiv is accepting.
Learn more

Funding goal

$1.07M

Predictiv must achieve its minimum goal of $25K before the deadline. The maximum amount the offering can raise is $1.07M.
Learn more

Deadline
Predictiv needs to reach their minimum funding goal before the deadline ( ). If they don’t, all investments will be refunded.
Learn more
Type of security

Crowd SAFE

A SAFE allows an investor to make a cash investment in a company, with rights to receive certain company stock at a later date, in connection with a specific event. · Learn more

How it works

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by Predictiv Care. View the official SEC filing and all updates:
Official SEC Logo Form C SEC.gov
Company documents
Predictiv Crowd SAFE Predictiv Form CA.pdf Predictiv Form C.pdf

Bonus perks

In addition to your Crowd SAFE, you'll receive perks for investing in Predictiv.
Invest
$150
Receive
  • $50 discount on Predictiv.care when you order your Digital Twin
Invest
$250
Receive
  • $100 discount on Predictiv.care when you order your Digital Twin
Invest
$500
Receive
  • $200 discount on Predictiv.care when you order your Digital Twin
Invest
$1,000
Receive
  • $400 discount on Predictiv.care when you order your Digital Twin
Invest
$2,000
Receive
  • 1 Digital Twin for free!
  • $400 discount on Predictiv.care for any additional Digital Twin
Invest
$10,000
Receive
  • 2 Digital Twins for free!
  • $400 discount on Predictiv.care for any additional Digital Twin
  • One exclusive meeting with our founders to discuss on the future of medicine

About Predictiv

Legal Name
Predictiv Care
Founded
Jul 2020
Form
Delaware Corporation
Employees
0
Website
predictivcare.com
Social Media
Headquarters
Google Map location of of Predictiv
2483 Old Middlefield Way , Mountain View, CA
Headquarters
2483 Old Middlefield Way, Mountain View, CA, United States 94043

Predictiv Team
Everyone helping build Predictiv, not limited to employees

Profile picture of Sajung Yun
Sajung Yun
CEO & Cofounder
Profile picture of Alex Rochegude
Alex Rochegude
COO & Cofounder
Profile picture of Sijung Yun
Sijung Yun
Chief Science Officer
Profile picture of Mhy-Lanie Adduru
Mhy-Lanie Adduru
Head of Medical
Profile picture of Alexander Brelsfoard
Alexander Brelsfoard
Head of Software Engineering
2 more team members
Sajung Yun
CEO & Cofounder
Alex Rochegude
COO & Cofounder
Sijung Yun
Chief Science Officer
Mhy-Lanie Adduru
Head of Medical
Alexander Brelsfoard
Head of Software Engineering

Press

Meet the CEO: Predictiv Is Mapping Health Risks From Fing...
Galen Growth Galen Growth
·
Jun 11, 2021

Every few weeks, we clip our fingernails and consider them redundant, but what if they could hold our health forecast for...

Deep dive with Sajung Yun CEO and Alex Rochegude CO found...
Spotify Spotify
·
Jun 10, 2021

We and our partners use cookies to personalize your experience, to show you ads based on your interests, and for measurem...

Predictiv Inc. Partners with SOMOS to Conduct Research an...
Digital Journal Digital Journal
·
Jun 9, 2021

The partnership between Predictiv and SOMOS is geared towards Hispanic people and ensuring that medical practitioners eff...

The future of medicine
Campaign-archive Campaign-archive
·
May 25, 2021

the future of medicine. By extracting DNA from just a fingernail/toenail sample, Predictiv creates an individual's "DNA d...

ZoneCast Episode 278: Predictiv
Spotify Spotify
·
May 6, 2021

For this episode of ZoneCast, I interviewed Sajung Yun, CEO of Predictiv.

Taking A Closer Look At AI-Driven Biomarkers
Plug and Play Tech Center
·
Apr 29, 2021

What are biomarkers? Biomarkers include everything from blood pressure, heart rate, basic metabolic studies, x-ray findin...

Invest in a 23&Me For Actual Doctors
Kitun
·
Apr 22, 2021

Heyyyo, Baby girl Gigi ( Georgia Scott Kitun) is here!! Little buggy and mama are happy and healthy ( but tired). As for ...

The 23&Me for doctors | Predictiv | Technori Pitch
YouTube YouTube
·
Apr 22, 2021

Predicitv has the ability to also sequence more than 20,000 genes and simulate hundreds of drugs reactions in real-time. ...

The VC Vodcast #10 - VC Famine, Entrepreneurial Tenacity,...
YouTube YouTube
·
Mar 11, 2021

The VC Vodcast is our weekly digest on Venture Capital, based on curated content from our Newsletter, which goes is read ...

Meet the Drapers | Season 4 - DraperTV
Drapertv Drapertv
·
Feb 13, 2021

Meet the Drapers, Brand Accelerator Speaker Series Meet The Drapers is a groundbreaking reality show in Silicon Valley wh...

Kayan Health Partners with Predictiv Care, Inc. to Offer ...
Newswire Newswire
·
Feb 9, 2021

VANCOUVER, BC, Feb. 9, 2021 /CNW/ - Beyond Medical Technologies Inc. (" Beyond Medical" or the " Company") (CSE: DOCT) (F...

Show all
Logo of Predictiv

Predictiv

Predictiv successfully raised $807,600 from 1575 investors on June 12, 2021
Profile picture of Baiping Guo
Profile picture of Dilprit Danny Takhar
Profile picture of Brian Belley
Profile picture of Shorty Callow
Profile picture of Daniel Uribe
Baiping, Dilprit Danny, Brian, Shorty, Daniel, and 1570 others invested. 283 Reviews
Republic

Giving everyone access to early-stage startup investing

For investors
  • Why invest
  • How it works
  • FAQ
  • Risks
  • Privacy policy
  • Accessibility
  • Cookie Preferences
  • Form CRS
For startups
  • Why raise
  • Learn
  • FAQ
  • Instruments
  • Crowd SAFE
  • Tokenized assets
Company
  • About
  • Journal
  • Events
  • Contact
  • We're hiring!
Dollar Refer a startup, get $2,500
Dollar Refer a startup, get $2,500

Invest in the app

Android app iOS app

Invest in the app

Android app iOS app

This site (the "Site") is owned and maintained by OpenDeal Inc., which is not a registered broker-dealer. OpenDeal Inc. does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this Site is the responsibility of, the applicable issuer of such securities. The intermediary facilitating the offering will be identified in such offering’s documentation.

All related securities activity is conducted by OpenDeal Broker LLC a registered broker-dealer, Member of FINRA and SiPC, an affiliate of OpenDeal Inc. and OpenDeal Portal LLC, located at 149 5th Avenue, 10th Floor, New York, NY 10010. Please check our background on FINRA’s BrokerCheck.

Certain pages discussing the mechanics and providing educational materials regarding regulation crowdfunding offerings may refer to OpenDeal Broker LLC and OpenDeal Portal LLC collectively as “Republic”, solely for explanatory purposes.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC make investment recommendations and no communication, through this Site, or in any other medium, should be construed as a recommendation for any security offered on or off this investment platform. Investment opportunities posted on this Site are private placements of securities that are not publicly traded, involve a high degree of risk, may lose value including the total loss of invested capital, are subject to holding period requirements and are intended for investors who do not need a liquid investment. Past performance is not indicative of future results. Investors must be able to afford the loss of their entire investment. Only qualified investors, who understand the risks of early-stage investment and who meet the Republic's investment criteria may invest. Investors may be restricted to only Accredited Investors or non-U.S. persons, to invest in offerings hosted by OpenDeal Broker. Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC, nor any of their officers, directors, agents and employees make any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy or completeness of any information on this Site or the use of information on this site. Offers to sell securities can only be made through official offering documents that contain important information about the investment and the issuers, including risks. Investors should carefully read the offering documents. Investors should conduct their own due diligence and are encouraged to consult with their tax, legal and financial advisors.

By accessing the Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy. Please also see OpenDeal Broker’s Business Continuity Plan and Additional Risk Disclosures. All issuers offering securities under regulation crowdfunding as hosted by OpenDeal Portal LLC are listed on the All Companies Page. The inclusion or exclusion of an issuer on the Platform Page and/or Republic’s Homepage, which includes offerings conducted under regulation crowdfunding as well as other exemptions from registration, is not based upon any endorsement or recommendation by OpenDeal Inc, OpenDeal Portal LLC, or OpenDeal Broker LLC, nor any of their affiliates, officers, directors, agents, and employees. Rather, issuers of securities may, in their sole discretion, opt-out of being listed on the Platform Page and Homepage.

Investors should verify any issuer information they consider important before making an investment.

Investments in private companies are particularly risky and may result in total loss of invested capital. Past performance of a security or a company does not guarantee future results or returns. Only investors who understand the risks of early stage investment and who meet the Republic's investment criteria may invest.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC verify information provided by companies on this Site and makes no assurance as to the completeness or accuracy of any such information. Additional information about companies fundraising on the Site can be found by searching the EDGAR database, or the offering documentation located on the Site when the offering does not require an EDGAR filing.

To help the government fight the funding of terrorism and money laundering activities, Federal law requires all financial institutions to obtain, verify, and record information that identifies each person who opens an account. Therefore, when you use the Services we will ask for your name, address, date of birth, and other information that will allow us to identify you. We may also ask to see your driver's license, passport or other identifying documents.

Republic and its affiliates are not and do not operate or act as a bank. Certain banking services are provided by BankProv, member FDIC / member DIF. FDIC coverage only applies in the event of bank failure. Digital (crypto) assets and investment products are not insured by the FDIC, may lose value, and are not deposits or other obligations of BankProv and are not guaranteed by BankProv. Terms and conditions apply.

Invest in startups using your credit card
You can invest using your credit card

Made in SF/NYC